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Abstract
Background: The aim of our study was to facilitate perioperative calculation of potential risk
factors on the outcome of corrective surgery for children with tetralogy of Fallot.
Methods: The medical records of 81 (44 female and 37 male) out of a total of 87 patients
undergoing complete surgical repair of tetralogy of Fallot between 1988 and 2004 at the
Children’s Hospital of the Johannes Gutenberg University of Mainz were reviewed. Patients
were divided into four categories, depending on the severity of pulmonary stenosis and cyanosis,
as well as on the type of pulmonary circulation.
Results: Additional malformations did not affect mortality rates, but did directly affect the
number of pleural effusions, time of epinephrine administration, duration of surgery, bypass,
and ischemia, as well as length of hospitalization and intensive care unit treatment. In
contrast to longer periods of extracorporeal circulation and ischemia during surgery, which are
directly related not only to more complex anatomical situations but also to higher mortality and
complication rates, the much-debated question of age at surgery had no influence either on the
surgical approach itself or on the post-operative outcome.
Conclusions: Our patient categorization, and evaluation of potential pre-operative risk fac-
tors and intraoperative parameters, should prove useful for the future planning and execution
of therapeutic procedures in institutions around the world. (Cardiol J 2010; 17, 1: 20–28)
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Introduction
Tetralogy of Fallot (ToF), first described in
1671 by the Danish anatomist Niels Stensen [1] and
named after the French physicist and pathologist
Etienne L.A. Fallot (1850–1911), is today the most
frequently occurring congenital cyanotic heart dis-
ease. It is characterized by four major morphologi-
cal changes of the heart: (1) a stenosis of the right
ventricular outflow and a stenosis of the pulmonary
valve; (2) a ventricular septal defect; (3) an ante-
and dextro-positioned overriding aortic root; and
(4) a secondary right ventricular hypertrophy.
According to a study at the Toronto Hospital for
Sick Children, it accounts for 9.7% of all congenital
heart conditions and is therefore the most frequent
cyanotic vitium cordis [2]. Owing to technical advanc-
es in cardiac surgery, pediatric anesthesiology and
pediatric intensive care, recent years have witnessed
significant changes in the diagnosis and treatment of
congenital heart diseases. The mean age of primary
complete repair surgery has steadily decreased. This,
based on the results of Barratt-Boyes and Neutze [3],
has generated controversy over the optimal time for
complete repair of ToF. Castaneda et al. [4], from the
Children’s Hospital in Boston, argue in favor of
primary correction at any age owing to the fact that
this procedure avoids the damaging effects of
a palliative shunt operation. It also reduces the de-
velopment of right ventricular hypertrophy and con-
sequently the occurrence of ventricular arrhythmias.
At first the latter findings did not gain widespread
recognition. But with the development of the new type
of prostaglandins in the mid-1970s, the arterial duct
could be kept open, which created a safe basis for
a low-risk early total correction [5].
The ongoing development of sophisticated in-
terventions caused a renewed discussion about the
influence of the size of the pulmonary arteries on
the outcome [6–8] and of the pre-operative stimu-
lation of their growth [9–12].
Opinions still differ as to whether early one-
stage repair of newborns is preferable to multi-stage
surgical intervention [13–16]. Several studies with
neonates and infants were conducted at the Toron-
to Hospital for Sick Children, which demonstrated
no difference in mortality between one- and two-
-stage surgery [17]. Nevertheless, total corrective
surgery is preferred today to palliative shunt sur-
gery at any age.
The present study focuses on retrospective
perioperative investigations of patients diagnosed
with ToF at the Children’s Hospital of the Johan-
nes Gutenberg University of Mainz between 1988
and 2004, where surgery was performed. Its aim
was to facilitate a pre-operative calculation of risk
by determining the influence of potential risk fac-
tors, including age, body weight, additional malfor-
mations, as well as hematocrit and hemoglobin con-
centration, on the outcome of the surgery. It also
served to allow better judgment of the influence of
intraoperative parameters, such as duration of sur-
gery, ischemia time, bypass time, body tempera-
ture, as well as the operative procedures on the
outcome and course of disease.
The results were helpful in the future planning
and execution of therapeutic measures at the Chil-
dren’s Hospital in Mainz. The comparison of our
results with those from other institutions around
the world facilitated a better evaluation of the qual-
ity of intensive care and patient management, and
resulted in improvements in our procedures.
Methods
The medical records of 81 (44 female and 37 male)
out of a total of 87 patients undergoing complete
surgical repair of ToF between 1988 and 2004 at the
Children’s Hospital of the Johannes Gutenberg Uni-
versity of Mainz were reviewed. The resulting data
are described below.
The study was approved by the local bioethical
committee and all patients gave their informed
consent.
Statistical analysis
The exploratory part of the study consisted of
a detailed statistical analysis of survival rate, fre-
quency of specific complications, and post-operative
development. Statistics were calculated using SPSS
software (version 14.0). P-values below 0.05 were
considered to be of statistical significance. We ex-
amined whether a statistical correlation between
the various parameters and the outcome exists.
‘Outcome’ was defined with the help of the follow-
ing seven variables:
1. Mortality within the first 10 days after surgery
2. General complications
3. Pleural effusions
4. Duration of mechanical ventilation
5. Duration of intensive care unit stay
6. Duration of hospital stay
7. Administration of catecholamines based on the
duration of epinephrine administration.
Our results were evaluated in the light of re-
cent literature.
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Results
Descriptive
Patient population. The age range was
13 days to 16.2 years, with 50 patients younger than
12.7 months at surgery. Median body weight at sur-
gery was 8.6 kg (total range: 2.6 to 47 kg) and me-
dian body size was 75 cm (total range: 44 to 162 cm).
Diagnostic groups. In contrast to other stu-
dies, the diagnosis included a differentiation into four
categories, depending on the severity of pulmonary
stenosis and cyanosis as well as on type of pulmo-
nary circulation. Twelve (14.8%) patients were dia-
gnosed with a so-called ‘Pink ToF’, 12 (14.8%) had
an uncomplicated ToF with mostly infundibular
pulmonary stenosis and only moderate cyanosis,
whereas 49 (60.5%) were diagnosed with a severe
pulmonary stenosis with pronounced cyanosis.
Eight (9.9%) patients suffered from pulmonary
atresia. Further data analysis differentiated be-
tween additional diagnoses of cardiac and non-car-
diac genesis (Table 1). Overall, 57 patients had one
or no additional diagnosis; 24 had two to four addi-
tional diagnoses. The most common intracardiac
additional malformation in the presented cohort was
an atrioventricular septal defect (AVSD) in 18.5%
of the population. Also the following anatomical
peculiarities were recorded: right descending aorta
(13 patients or 16.1%), major aorto-pulmonary col-
lateral arteries (eight patients or 9.9%), persisting
arterial duct (nine patients or 11.1%), and anomalous
origin of the coronary arteries not allowing
a transanular correction (nine patients or 11.1%).
Pre-operative laboratory parameters. The
average hemoglobin concentration was measured at
14.5 ± 2.9 g/dL (min. 9.6 g/dL; max. 23.0 g/dL). Out
of 81 patients, 49 had a hemoglobin concentration
between 10 and 15 g/dL; for 25 this was between
15 and 20 g/dL. Two patients were below or at
10 g/dL, four were over 20 g/dL. Hematocrit con-
centration was measured in 79 patients, with three
patients at or below 30%, 33 patients at 30 to 40%,
39 patients at 40 to 60%, and four patients over 60%.
Intraoperative data collection was taken from
the surgical reports of the Department of Car-
diothoracic and Vascular Surgery at the University
Hospital in Mainz. It showed that 39 of the opera-
tions lasted less than 237.5 minutes (with an overall
range from 135–670 min). The operations involved
median sternotomy with cardiopulmonary bypass,
mostly in hypothermia with an intraoperative mean
temperature of 26.2°C (range: 18.0–37.0°C). The by-
pass time for 50% of the operations was below
140 minutes (range: 80–521 min). Ischemia time was
no longer than 78 minutes for half of the operations
(minimum 40, maximum 205 min). In one patient,
a hypothermic circulatory arrest of 59 minutes was
performed at a body temperature of 18.0°C to cor-
rect additional subtotal coarctation.
Post-operative data. Duration of hospital stay
was between nine and 105 days for 80 patients (no
data for one patient). Half of them could be dis-
charged after no more than 24 days. After a maxi-
mum of 60 days, 75 of the patients had been dis-
charged, which included 64 after no more than
40 days. Five patients were treated post-operatively
for more than two months. One of these remained
in hospital for 105 days.
There was an equally broad span (3–93 days)
of the duration of intensive care unit (ICU) stay. For-
ty patients could be discharged from the ICU after
no more than ten days. After 20 days, 63 had been
released from the ICU, while eight patients remained
there for up to 40, and six between 41 and 100 days.
Half of the patients (n = 40) required post-
-operative ventilation for no more than four days
Table 1. Additional diagnoses.
Number Frequency
of patients  (%)
Additional diagnoses of cardiac genesis
Atrioventricular septal defect 15 18.5
Peripheral pulmonary stenosis 14 17.3
Double outlet right ventricle 12 14.8
Branching anomaly of 9 11.1
coronary artery
Hypoplastic pulmonary 6 7.4
arteric trunk
Persisting left superior vena cava 6 7.4
Double aortic arch 3 3.7
Functional bicuspid aortic valve 3 3.7
Aortic coarctation 1 1.2
Aneurysm of pulmonary arteries 1 1.2
Ebstein’s anomaly of 1 1.2
tricuspid valve
Additional diagnoses of non-cardiac genesis
Trisomy 21 6 7.4
Cleft lip and palate 3 3.7
Dystrophia 2 2.5
Continuity of hemiazygos vein 2 2.5
Microdeletion 22q11 2 2.5
VACTERL association 1 1.2
Meningomyelocele 1 1.2
Esophageal and anal atresia 1 1.2
Pyloric stenosis 1 1.2
Hypothyroidism 1 1.2
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(two days controlled and two days assisted). Six patients
were ventilated with continous positive airway
pressure for a maximum of four days. The minimal
duration of ventilation was one day, the maximum
32 days (23 days for controlled and 15 days for as-
sisted ventilation).
Administration of circulatory modifying
drugs. All but seven patients were administered
epinephrine for a mean duration of 4.3 ± 3.4 days
(seven patients for 1–3 days; 20 patients between
4–7 days and 15 patients for 7+ days). Norepine-
phrine was administered to 30 patients (13 between
1–3 days; 11 between 4–7 days; six for 7+ days).
Dobutamine was administered in four cases (only
one for 7+ days). Milrinone was administered in
nine cases (in two cases for less than three days, in
one case for more than seven days). Fifty-four patients
were given trinitrosan (in 38 cases for 1–3 days,
in 13 cases for 4–7 days, and in three cases for 7+days).
Natrium-nitroprusside was administered to 21 pa-
tients (in 13 cases for 1–3 days, in five cases for 4–
–7 days and in three cases for 7+ days). Dopamine
was given to 46 patients (in 16 cases for 1–3 days, in
22 cases for 4–7 days and in eight cases for 7+ days).
Complications. Twenty-two patients had no
post-operative complications, 22 had one, and
34 had between two and five complications after sur-
gical repair. One third of the patients suffered from
pleural effusion, and patients frequently faced car-
diac arrhythmia. Among the 81 patients there were
five post-operative deaths (four male and one fe-
male) and one late death (about six months after
corrective surgery).
Results
Explorative
There was no correlation between gender or
body weight and post-operative outcome. Howev-
er, body weight had a slightly negative influence on
the duration of hospital stay (r = –0.19), which
means that, in general, higher body weight result-
ed in a shorter hospital stay.
While there was no correlation between the
patients’ age and the other variables mentioned
above, we found a positive correlation between the
patients’ age and survival rate (p = 0.082), but this
did not attain statistical significance. Post-operative
mortality tended to be higher in younger patients.
The severity of diagnosis had no impact on the
survival rate or on the occurrence of complications,
including pleural effusions. There were also no dif-
ferences in the mean time of mechanical ventilation.
However, there appeared to be a direct correlation
between the severity of the diagnosis and the du-
ration of ICU and hospital stay, as well as the need
for positive inotropic support. Statistical analysis
showed clear differences between the mean values
in these three categories. A series of Dunnet-T3
tests allowed the identification of which particular
diagnosis groups displayed these differences. The
results were that patients diagnosed with  ‘Pink
ToF’ or ‘uncomplicated ToF’ had a significantly
shorter hospital stay than patients with ‘complicated
ToF’ or pulmonary atresia (Fig. 1). Similar results were
found with regard to the duration of ICU stay (Fig. 2).
In addition, it was noticeable that patients with
pulmonary atresia spent more time in hospital (37.5 vs
32.2 days), but less time in ICU (19 vs 16.5 days) than
patients with a ‘complicated ToF’.
Most patients had no (n = 26), one (n = 30) or
two (n = 14) additional diagnoses and no (n = 22), one
(n = 22) or two (n = 19) post-operative complications.
A total of 32.1% of patients suffered from post-
operative pleural effusions. The number of additional
diagnoses showed no correlation to the survival rate,
the duration of hospital stay and ICU stay. However,
there were positive correlations with the complications
in general (p = 0.030) as well as with pleural effusions
(p = 0.012), and in particular with the mean duration
of epinephrine administration (p = 0.002) (Table 2).
Figure 1. Mean duration of hospital stay (in days) de-
pending on diagnosis.
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The Dunnet-T3 test could not reveal specifi-
cally how the individual diagnosis groups differed,
but there was a tendency towards a longer duration
of mechanical ventilation (p = 0.078) and of a high-
er number of post-operative complications for pa-
tients with more additional diagnoses. While there
was no correlation between the number of additional
diagnoses and the probability of pleural effusion, it
was noticeable that all three patients with the high-
est number of additional diagnoses suffered from
pleural effusions. Neither the Wilcoxon-Mann-
-Whitney-U-test, nor the correlation coefficient af-
ter Spearman, showed any correlation between
C-reactive protein and the occurrence of pleural ef-
fusions, duration of ventilation, duration of hospi-
tal and ICU stay, and administration of epinephrine.
Nevertheless, pre-operative C-reactive protein was
higher in patients who did not survive (p = 0.014).
There was no correlation between the duration
of surgery and the frequency of pleural effusions.
However, there was a strong positive correlation
between the duration of surgery and the duration
of post-operative ventilation (r = 0.454; p = 0.000).
A similar consistency between the duration of sur-
gery and the duration of hospital stay (r = 0.270;
p = 0.017), the duration of ICU stay (r = 0.456;
p = 0.000) and the duration of epinephrine admin-
istration (r = 0.426; p = 0.000) could be observed.
The time of bypass had no influence on the fre-
quency of pleural effusions. However, the patients
who died subsequently displayed a significantly long-
er time of bypass. Simple regression analysis showed
that the time of bypass could explain 27% of the
variance in the time of epinephrine administration, as
well as 12% of the variance of the duration of ICU stay.
The Wilcoxon-Mann-Whitney-U test showed
that patients with pleural effusions and non-surviv-
ing patients on average had a longer time of
ischemia (p = 0.085 and p = 0.031, respectively).
Simple regression analysis showed that the time of
ischemia could explain nearly 20% of the variance
in the administration of epinephrine and nearly 15%
of the variance in duration of ventilation.
In general, we found no correlation between
intraoperative body temperature and outcome, al-
though a difference was seen in the occurrence of
pleural effusions (p = 0.054): the lower the body
temperature during surgery, the higher the proba-
bility of effusions.
Duration of surgery, as well as time of bypass
and ischemia, was shortest in the patient group
with ‘Pink ToF’. Patients with ‘complicated ToF’
had the longest surgery and bypass time, while the
‘pulmonary atresia’ group featured the longest
ischemia time. Patients with fewer additional di-
agnoses needed a shorter time of surgery and
a short mean time of bypass. We found no differ-
ence in time of ischemia between the different
patient groups.
The need for more and advanced antibiotic re-
gimes increased with the duration of use of bladder
catheters, of mechanical ventilation, and of central
venous catheters.
Table 2. Influence of additional diagnoses on the
outcome.
Outcome P
Survival 0.302*
Complications 0.030*
Pleural effusion 0.012*
Ventilation 0.078**
Duration of hospital stay 0.563**
Duration of ICU stay 0.389**
Administration of epinephrine 0.002**
*Pearson c2 test, **univariate analysis of variance; ICU — intensive
care unit
Figure 2. Mean duration of intensive care unit stay (in
days) depending on diagnosis.
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Discussion
The goal for all patients was the total repair of
ToF, either through primary complete repair sur-
gery, or through secondary surgery after an initial
palliative shunt operation. The criteria for deciding
the initial therapeutic regime could not be taken into
account in the context of this study.
Risk factors
In general, all additional malformations must
be regarded as risk factors [18]. Forty-six of
81 patients (56.8%) had at least one additional cardiac
malformation, the most common being an AVDS
(18.5%), followed by peripheral pulmonary stenosis
(17.3%) and double outlet right ventricle (14.8%).
Nineteen (23.5%) featured at least one extracardi-
ac malformation or disease, and ten (12.3%) had
both cardiac and non-cardiac additional diagnoses.
These figures are significantly higher than the
comparable figures in the literature, which trans-
lates into a higher risk for our patients. In other
studies, patients with a constellation of ToF and
AVSD were generally excluded from statistical anal-
ysis because of the rarity of this combined defect,
the difficulty of corrective surgery, the longer time
of bypass and ischemia, and, not least, the reduced
survival rate [19]. Post-operative mortality was
found to be as high as 18% [20]. In our cohort, how-
ever, none of the patients with ToF and AVSD died
or required re-surgery, although nine out of 15 re-
ceived a Blalock-Tausing shunt prior to corrective
surgery.
Patient body
Of our 81 patients, 52 underwent primary and
29 multi-stage surgical repair. Comparison with
studies of similar size and with similar data collec-
tion periods (Tables 3–5) showed that the mean age
of surgery lies between 16 ± 13 days and
13 months. Nearly half (39) of our patients were aged
less than one year at the time of surgery (range from
13 days to 16 years). In regard to the ongoing dis-
cussion about optimal age of surgery, we found that
age had no influence on the course and outcome of
the surgery. Furthermore, gender had no influence
on the outcome of the surgery, although it has to
be noted that our gender distribution was charac-
terized by an unusually large proportion of female
patients. But on average, patients with lower body
weight required an increased time of hospital stay.
The approach of sub-dividing patients into four
groups according to the degree of pulmonary ste-
nosis and the development of the pulmonary arter-
ies, is unique to this study. It facilitated a connec-
tion between diagnosis and time of ICU and hospi-
Table 3. Comparison of general and pre-operative data in Mainz, Toronto, Michigan, and Boston.
Children’s Toronto C.S. Mott Boston
Hospital,  Hospital Children’s Children’s
University for Sick Hospital, Hospital
of Mainz Children University
of Michigan
Examination period 1988–2004 1987–1994 1988–1999 1988–1996
Number of patients 81 89 61 99
Pulmonary atresia 8 4 24 26
Male/female 37/44 65/24 41/20 55/44
Age at operation 12.68 months 13 months 16 ± 13 days 32.9 ± 26.7 days
(range: 13 days – (range: 15 days – (range: (range:
– 16.17 years)   – 17.9 months) 0–43 days)  2–87 days)
< 6 months 15 9 61 99
Body weight 8.6 kg 8.5 kg 3.2 ± 0.7 kg 3.3 ± 0.7 kg
(range:  (range:  (< 30 days)
2.62–47 kg) 2.6–17.6 kg) + 0.2 ± 0.9 kg
(31–87 days)
Trisomy 21 6 5
VATER syndrome 1 1
Right descending aortic arch 13 16
Multiple aortopulmonic 8 7
collateral arteries
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tal stay, and a longer time of bypass and ischemia
with complicated anatomical conditions. Therefore,
the proposed scheme of division seems useful for
future risk management and therapy planning.
The statistical analysis of data confirmed that
patients with several additional diagnoses suffered
from post-operative pleural effusion more frequent-
ly and were administered epinephrine for a longer
period. In addition, these patients suffered a long-
er time of surgery, bypass and ischemia. However,
there was no influence between the number of ad-
ditional diagnoses and mortality rates. This contra-
dicts the findings of Garne et al. [21], who found an
increase in mortality in patients with extracardiac
malformations.
Post-operative outcome
In the immediate post-operative period, the
mortality rate at Mainz was 6.2%. It was evident
that age, weight, as well as primary and additional
Table 5. Comparison of post-operative data in Mainz, Toronto, Michigan, and Boston.
Children’s Toronto C.S. Mott Boston
Hospital, Hospital Children’s Children’s
University for Sick Hospital, Hospital
of Mainz    Children University
of Michigan
Early mortality 5 patients 6 patients 1 patient 3 patients
(6.2%) within (6.7%) within (1.6%) within (3%) within
10 days 48 hours 2 months 30 days
post-operatively    post-operatively    post-operatively
Duration of hospital stay 24 days 19 days 16.5 ± 15.3 days
(range: 9–105 days) (range: 6–200 days) (< 30 days)
11.2 ± 7.7 days
(range: 31–87 days)
Duration of intensive 10 days 5 days  9.1 ± 8.3 days 9.6 ± 13.5 days
care unit stay (range: 3–93 days)  (range: 1–40 days)  (n = 37)  (< 30 days)
6 ± 4.7 days
(range: 31–87 days)
Duration of ventilation 4 days 3.08 days (74 h) 6.8 ± 7 days 5.1 ± 4.6 days
(range: 1–32 days)   (range:  (n = 39)  (< 30 days)
11 h – 30 days) 3.5 ± 3.2 days
(range: 31–87 days)
Early arrhythmias 24 patients 24 patients 29 patients
(29.6%)  (27%)  (29%)
Table 4. Comparison of intraoperative data in Mainz, Toronto, Michigan, and Boston.
Children’s Toronto C.S. Mott Boston
Hospital, Hospital Children’s Children’s
University for Sick Hospital, Hospital
of Mainz Children University
of Michigan
Mean time of bypass 140 min 119 ± 37 min 71 ± 26 min 108.6 ± 278 min
(range: 80–521 min)  (n = 88) (< 30 days)
(n = 78) 96.4 ± 24.8 min
(31–87 days)
Mean time of ischemia 78 min 47 ± 14 min 45 ± 15 min 56.1 ± 12.1 min
(range: 40–205 min) (n = 88) (n = 52) (< 30 days)
(n = 79) 49.3 ± 15.6 min
(31–87 days)
Transventricular access 9 79 (n = 85) 23 96
Transannular patch 39 55 (n = 87) 49 70
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diagnoses did not have a noticeable influence on
early mortality. However, the pre-operative C-re-
active protein was on average higher in non-surviv-
ing patients. The course of the operation (duration,
time of bypass and ischemia) showed an influence
on early mortality. It was also dependent on the
severity of pulmonary stenosis, the development of
the cardiopulmonary system and the number of
additional diagnoses. In general, the pre-operative
anatomical and clinical situation had an indirect in-
fluence on the mortality rates during the first ten
days after corrective surgery.
Pigula et al. [22] found a smaller body surface
area and a diagnosis of ToF with pulmonary atresia
to be independent risk factors for higher mortality,
whereas age at surgery, gender, weight, size of
pulmonary arteries and pulmonary valves, duration
of circulatory arrest, time of bypass and ischemia,
and the administration of inotropic drugs did not
constitute risk factors. In contrast, Niwa et al. [23]
demonstrated age at surgery, as well as the neces-
sity for (and course of) re-operations, to be risk fac-
tors for late mortality.
According to Di Donato et al. [24], early mor-
tality after corrective surgery for ToF between 1973
and 1988 was as high as 18.5%. In a retrospective
study over a period of 26 years, Knott-Craig et al.
[25] documented a decrease in all age groups from
11.1% before 1990 to 2.1% after 1990. A 2000 study,
which included all operations of 11 different sur-
geons in five English institutions, showed an aver-
age mortality of 2.3% for cases with ToF (ranging
from 1.6 to 6.9%, depending on the surgeon) [26].
The results at Mainz are comparable with the data
in the literature and with other relevant studies.
The survival rate at Mainz was slightly higher
than in the Toronto Hospital for Sick Children, but
lower than in the other two institutions, but the
results presented from these institutions do not
include patients with ToF and AVSD. The devia-
tions are comparable to rates in the literature. In
Mainz, duration of hospital stay and ICU stay was,
respectively, five days and one day longer than in
Michigan. This can be explained by differences in
manner of calculation. The mean duration of venti-
lation was roughly one day longer than in Toronto
and three days shorter than in Michigan. In com-
parison to Boston, the mean duration of ventilation
was half a day longer for older patients (31–87 days
at surgery) and one day shorter for younger patients
(30 days and under).
Vohra et al. [27], who compared eight papers on
the topic of optimal age of correction of ToF, confirmed
our finding that early primary repair is comparable to
later repair in regard to mortality and re-intervention
in infants aged under six months , but that length of
ICU stay, requirement for ventilation and the need for
inotropes is increased in patients undergoing prima-
ry surgical repair at under three months.
Conclusions
In accordance with current practice, the Chil-
dren’s Hospital tends to perform total surgical re-
pair of ToF at an increasingly early age. The patient
collective analyzed here displayed frequent addi-
tional malformation of cardiac and extracardiac gen-
esis, which resulted in an increased perioperative
risk. Nevertheless, the outcome of our study was
comparable to those from three large specialized
centers in North America: the C.S. Mott Children’s
Hospital at the University of Michigan [28], the
Boston Children’s Hospital [29], and the Hospital
for Sick Children in Toronto [30].
The patients were found to be at increased risk
owing to a higher percentage of cardiac and extrac-
ardiac additional diagnoses. Mortality was not in-
fluenced by the number of additional diagnoses, al-
though patients with a higher number of them suf-
fered more frequently from pleural effusions,
needed epinephrine for a longer time, and had an
increased duration of surgery, of bypass, and of
ischemia. It therefore proved useful to divide pa-
tients into groups according to their diagnoses. This
showed that an increased duration of bypass and
ischemia resulted in a longer hospitalization and
treatment in the intensive care unit, which will be
of interest for future risk management and therapy
planning. With regard to the much-debated optimal
surgery age, no influence was noted on the surgery
itself and the post-operative outcome in our patient
cohort (mean age of one year).
In contrast, the effect of the surgery proved to
be of significant influence on post-operative out-
come. The longer the extracorporeal circulation and
period of ischemia, which are related to more com-
plicated anatomical situations and additional malfor-
mations and diseases, the higher the mortality rate
and number of post-operative complications. The
duration of ventilation, period of ICU stay and hos-
pital stay is also longer. All this coincides with
a higher need for catecholamines.
In this study, the mortality rate was indirectly
influenced by the clinical and anatomical situation
and at 6.2% proved comparable to other studies. The
duration of ventilation and the extended need for
a urinary catheter and a central venous catheter
depended on perioperative course of operation and
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resulted in an increased need for inotropic drugs and
advanced antibiotic regimens. The results of this study
are comparable to findings in other cardiological
centers at Toronto, Michigan and Boston. Differences
in the duration of hospitalization can be explained by
differences in organization and accounting procedures.
Acknowledgments
The first two authors listed contributed equal-
ly to this article.
The authors wish to thank Dr. Frank Erdnuess,
Wiesbaden, for his help in preparing this manu-
script.
The authors do not report any conflict of inter-
est regarding this work.
References
1. Stensen N. Quoted by Goldstein. Bull Hist Med, 1984; 22: 526.
2. Baek WK, Kim JT, Yoon YH et al. Huge sinus of Valsalva aneu-
rysm causing mitral valve incompetence. Ann Thorac Surg,
2002; 73: 1975–1977.
3. Barratt-Boyes BG, Neutze JM. Primary repair of tetralogy of
Fallot in infancy using profound hypothermia with circulatory
arrest and limited cardiopulmonary bypass: A comparison with
conventional two stage management. Ann Surg, 1973; 178: 406–411.
4. Castaneda AR, Freed MD, Williams RG, Norwood WI. Repair of
tetralogy of Fallot in infancy. Early and late results. J Thorac
Cardiovasc Surg, 1977; 74: 372–381.
5. Olley PM, Coceani, F, Bodach E. E-type prostaglandins: A new
emergency therapy for certain cyanotic congenital heart malfor-
mations. Circulation, 1976; 53: 728–731.
6. Blackstone EH, Kirklin JW, Bertranou EG et al. Preoperative
prediction from cineangiograms of postrepair right ventricular
pressure in tetralogy of Fallot. J Thorac Cardiovasc Surg, 1979;
78: 542–552.
7. Nakata S, Imai Y, Takanashi Y et al. A new method for the
quantitative standardization of cross-sectional areas of the
pulmonary arteries in congenital heart diseases with
decreased pulmonary blood flow. J Thorac Cardiovasc Surg,
1984; 88: 610–619.
8. Kaulitz R, Jux C, Bertram H, Paul T, Ziemer G, Hausdorf G.
Primary repair of tetralogy of Fallot in infancy — the effect on
growth of the pulmonary arteries and the risk for late reinter-
ventions. Cardiol Young, 2001; 11: 391–398.
9. Qureshi SA, Kirk CR, Lamb RK, Arnold R, Wilkinson JL. Bal-
loon dilatation of the pulmonary valve in the first year of life in
patients with tetralogy of Fallot: a preliminary study. Br Heart J,
1988; 60: 232–235.
10. Sluysmans T, Neven B, Rubay J et al. Early and late results and
the effects on pulmonary arteries of balloon dilatation of the
right ventricular outflow tract in tetralogy of Fallot. Eur Heart J,
1998; 19: 595–600.
11. Heusch A, Tannous A, Krogmann ON, Bourgeois M. Balloon
valvoplasty in infants with tetralogy of Fallot: effects on oxy-
gen saturation and growth of the pulmonary arteries. Cardiol
Young, 1999; 9: 17–20.
12. Arnold R. Is balloon dilatation a reasonable option for the palliation
of the Fallot‘s tetralogy? Comments. Cardiol Young, 1999; 9: 4–5.
13. Pozzi M, Trivedi DB, Kitchiner D, Arnold RA. Tetralogy of Fal-
lot: What operation, at which age. Eur J Cardiothorac Surg, 2000;
17: 631–636.
14. Dodge-Khatami A, Tulevski II, Hitchcock JF, De Mol BA,
Bennink GB. Neonatal complete correction of tetralogy of Fallot
versus shunting and deferred repair: is the future of the right
ventriculo-arterial junction at stake, and what of it? Cardiol
Young, 2001; 11: 484–490.
15. Navabi Shirazi MA, Ghavanini AA, Sajjadi S. Early postoperative
results after total correction of tetralogy of Fallot in older pa-
tients: Is primary repair always justified? Pediatr Cardiol, 2001;
22: 238–241.
16. Van Arsdell GS, Maharaj GS, Tom J et al. What ist he optimal
age for repair of tetralogy of Fallot? Circulation, 2000; 102: 123–129.
17. Vobecky SJ, Williams WG, Trusler GA et al. Survival analysis of
infants under age 18 months presenting with tetralogy of Fallot.
Ann Thorac Surg, 1993; 56: 944–949.
18. Hausdorf G. Intensivtherapie angeborener Herzfehler. Steinkopff
Verlag 2000: 414–422.
19. Suzuki T, Bove EL, Devaney EJ et al. Results of definitive re-
pair of complete atrioventricular septal defect in neonates and
infants. Ann Thorac Surg, 2008; 86: 596–602.
20. Prifti E, Crucean A, Bonacchi M et al. Total correction of com-
plete atrioventricular septal defect with tetralogy of Fallot.
J Heart Valve Dis, 2003; 12: 640–648.
21. Garne E, Nielsen G, Hansen OK, Emmertsen K. Tetralogy of
Fallot. A population-based study of epidemiology, associated
malformations and survival in western Denmark 1984–1992.
Scand Cardiovasc J, 1999; 33: 45–48.
22. Pigula FA, Khalil PN, Mayer JE, del Nido PJ, Jonas RA. Repair of
tetralogy of Fallot in neonates and young infants. Circulation,
1999; 100: 157–161.
23. Niwa K, Hamada H, Nakazawa M, Terai M et al. Mortality and
risk factors for late deaths in tetralogy of Fallot: The Japanese Na-
tionwide Multicentric Survey. Cardiol Young, 2002; 12: 453–460.
24. Di Donato RM, Jonas RA, Lang P, Rome JJ, Mayer JE, Castaneda AR
Neonatal repair of tetralogy of Fallot with and without pulmo-
nary atresia. J Thorac Cardiovasc Surg, 1991; 101: 126–137.
25. Knott-Craig CJ, Elkins RC, Lane MM et al. A 26-year experi-
ence with surgical management of tetralogy of Fallot: Risk anal-
ysis for mortality or late reintervention. Ann Thorac Surg, 1998;
66: 506–511.
26. Stark J, Gallivan S, Lovegrove J et al. Mortality rates after sur-
gery for congenital heart defects in children and sugeons’ per-
formance. Lancet, 2000; 355: 1004–1007.
27. Vohra HA, Adamson L, Haw MP. Is early primary repair for
correction of tetralogy of Fallot comparable to surgery after
6 months of age? Interactive CardioVascular Thoracic Surg,
2008; 7: 698–701.
28. Hirsch JC, Mosca RS, Bove EL. Complete repair of tetralogy of
Fallot in the neonate: results in the modern era. Ann Surg, 2000;
232: 508–514.
29. Sluysmans T, Neven B, Rubay J et al. Early balloon dilatation of
the pulmonary valve in infants with tetralogy of Fallot. Risks and
benefits. Circulation, 1995; 91: 1506–1511.
30. Dyamenahalli U, McCrindle BW, Barker GA, Williams WG,
Freedom RM, Bohn DJ Influence of perioperative factors on
outcomes in children younger than 18 months after repair of
tetralogy of Fallot. Ann Thorac Surg, 2000; 69: 1236–1242.
